Amyotrophic lateral sclerosis and frontotemporal dementia represent opposite ends of a disease spectrum with significant clinical, pathological, and genetic overlap. Understanding the vulnerable neuron populations in this spectrum is crucial for developing targeted therapies.
The ALS-FTD spectrum represents a continuum of neurodegenerative diseases:
- Pure ALS: ~70% of cases
- ALS-FTD Overlap: ~15% of ALS patients meet criteria for FTD
- FTD-ALS: ~15% of FTD patients have ALS features
- Pure FTD: Without motor neuron involvement
- Genetics: C9orf72 is the major shared genetic cause
- Pathology: TDP-43 protein inclusions
- Mechanisms: RNA metabolism dysfunction, proteostasis failure
- Progression: Both diseases are relentlessly progressive
- Betz Cells (Layer V): Large pyramidal neurons in primary motor cortex
- Cortical Projection Neurons: Precentral gyrus
- Vulnerability: Early degeneration, corticospinal tract loss
- Pathology: TDP-43 inclusions, skein-like inclusions
- Alpha Motor Neurons: Spinal anterior horn cells
- Brainstem Motor Nuclei: Hypoglossal, vagus, ambiguus
- Cranial Nerve Motor Neurons: Oculomotor sparing common
- Pattern: Distal > proximal, flexor > extensor
- Von Economo Neurons: Specifically vulnerable in FTD
- Cortical Association Neurons: Frontotemporal network
- Vulnerability: Early in behavioral variant FTD
- Pathology: TDP-43, sometimes tau or FUS
- Layer V Projection Neurons: Subcortical outputs
- Layer VI Corticothalamic Neurons: Thalamic feedback
- Network Dysfunction: Frontostriatal circuits
- CA1 Pyramidal Cells: Memory circuitry
- Dentate Gyrus Granule Cells: Pattern separation
- Subiculum: Output pathway
- Involvement: Especially in semantic variant FTD
- Von Economo Neurons: Similar to frontal cortex
- Temporopolar Cortex: Early semantic deficits
- Inferior Temporal: Object recognition
- Medium Spiny Neurons: Particularly in C9orf72 cases
- Striosomes: Emotional/motivational circuitry
- Matrix: Motor and cognitive functions
- Nucleus Basalis of Meynert: Memory and attention
- Early Involvement: Cognitive correlates
- Cholinergic Loss: Contributes to dementia
- Anterior Nucleus: Memory relay
- Mediodorsal Nucleus: Executive function
- Centromedian Nucleus: Arousal
- Location: Cytoplasmic inclusions
- Phosphorylation: Hyperphosphorylated TDP-43
- Ubiquitination: Ubiquitin-positive
- Cleavage: C-terminal fragments
- Skein-like Inclusions: Filamentous, in ALS
- Neuronal Cytoplasmic Inclusions (NCIs): Round, compact
- Neuronal Intranuclear Inclusions (NIIs): Rare in ALS, common in FTD
- ** dystrophic neurites**: Axonal pathology
- RNA Toxicity: Repeat-containing RNA forms foci
- Dipeptide Repeat Proteins (DPRs): Translation of expanded repeats
- Nucleolar Stress: rRNA processing disruption
- Nuclear Pore Dysfunction: Transport impairment
- Poly-GA: Most abundant, detergent-insoluble
- Poly-GP: Less aggregation-prone
- Poly-PR: Highly neurotoxic
- Poly-GR: Arginine-rich, most toxic
- ALS6: FUS mutations cause ALS-FTD
- Cytoplasmic FUS: Loss of nuclear function
- Stress Granules: Abnormal processing
- CBD Overlap: Corticobasal degeneration features
- 4R Tau: Isoform-specific pathology
- NFTs: Neurofibrillary tangles
- Splicing Dysregulation: Aberrant splicing patterns
- Transport Defects: mRNA localization impaired
- Translation: Protein synthesis alterations
- miRNA Dysfunction: Regulatory RNA changes
- Protein Aggregation: TDP-43 inclusions
- Autophagy Dysfunction: Clearance mechanisms impaired
- UPS Failure: Ubiquitin-proteasome overload
- ER Stress: Unfolded protein response
- Mitochondrial Dysfunction: Energy failure
- Metabolic Changes: Glucose hypometabolism
- Calcium Dysregulation: Excitotoxicity
- Oxidative Stress: ROS accumulation
- Microglial Activation: Pro-inflammatory cytokines
- Astrocyte Reactivity: Loss of support functions
- T Cell Infiltration: Adaptive immune response
- Cytokine Release: Neurotoxic environment
- Antisense Oligonucleotides: Targeting C9orf72, SOD1
- Gene Editing: CRISPR approaches
- RNAi: Knockdown strategies
- TDP-43 Modulators: Reduce aggregation
- DPR-Targeting: GA, GR, PR reduction
- Autophagy Enhancers: Clearance promotion
- Molecular Chaperones: Protein folding help
- Riluzole: Glutamate modulation
- Edaravone: Antioxidant
- Respiratory Support: Non-invasive ventilation
- Assistive Devices: Mobility aids
- SSRIs: Behavioral symptoms
- Antipsychotics: Psychosis management
- Speech Therapy: Communication support
- Occupational Therapy: Daily function
- Neurofilament Light Chain: Disease progression
- CSF TDP-43: Pathology marker
- PET Tracers: Inflammatory, metabolic
- EEG/EMG: Electrophysiological markers
- ALS-FTD spectrum (2022)
- C9orf72 and neurodegeneration (2021)
- TDP-43 pathology in ALS-FTD (2023)
- Motor neuron vulnerability in ALS (2022)
- Frontotemporal networks in FTD (2023)